stockrow
Saturday 7 November 2026
Export LNAI’s income statement to Excel — free account
Lunai Bioworks Inc.
LNAI Healthcare Biotechnology
Lunai Bioworks Inc.’s revenue for fiscal 2026 (year ended June 2026) was $52,000.00.
- EPS
- +99.0%
- Free cash flow
- −1.65%
Quarter to June 2026, against a year earlier
0.16
0.00
0.00%
Follow LNAI
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(308.01%) | (366.44%) | (325.46%) | 23.46% | |
| (203.39%) | (212.74%) | (201.09%) | (39.21%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
692.65% | 644.58% | 825.67% | 21.13% | |
Average Days of Receivables |
— | — | — | 0.00 | |
Free Cash Flow per Share |
(2.56) | (1.97) | (1.69) | (1.58) | |
Free Cash Flow |
(7.21) | (5.79) | (5.29) | (5.31) | |
Capital Expenditures |
— | (0.07) | (0.03) | (0.02) | |
| Other line items | |||||
Cash ROIC |
58.05% | 44.35% | 82.65% | 72.67% | |
Accounts Receivable Turnover |
— | — | — | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 25.87% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 8,236.54% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
(288.43) | (270.10) | (315.03) | (40.46) | |
Operating CF/Net income |
0.06 | 0.05 | 0.04 | 1.48 | |
Depreciation/Fixed assets |
13,646.76 | 9,246.65 | 9,460.75 | 14.46 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | (0.14) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.03 | |
Operating CF per Share |
(2.56) | (1.95) | (1.68) | (1.57) | |
Capex per Share |
0.00 | (0.02) | (0.01) | (0.01) | |
Capex to Sales |
— | 0.00 | 0.00 | 0.26 |
Columns are period end dates · fundamentals updated 2 Nov 2026